{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:10:36Z","timestamp":1787317836716,"version":"build-2736575974"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.euroneuro.2023.02.012","type":"journal-article","created":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T12:39:53Z","timestamp":1677760793000},"page":"56-62","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Clinician- versus caregiver-rated scales as outcome measures of repetitive-restricted behaviors in clinical trials of autism: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"70","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8264-2039","authenticated-orcid":false,"given":"Spyridon","family":"Siafis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Leucht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2023.02.012_bib0001","first-page":"492","article-title":"Psychometric characteristics of the aberrant behavior checklist","volume":"89","author":"Aman","year":"1985","journal-title":"Am. J. Ment. Defic."},{"key":"10.1016\/j.euroneuro.2023.02.012_bib0002","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/2040-2392-3-16","article-title":"Intranasal oxytocin versus placebo in the treatment of adults with autism spectrum disorders: a randomized controlled trial","volume":"3","author":"Anagnostou","year":"2012","journal-title":"Mol. Autism"},{"key":"10.1016\/j.euroneuro.2023.02.012_bib0003","series-title":"Diagnostic and Statistical Manual of Mental disorders: DSM-5","year":"2013"},{"key":"10.1016\/j.euroneuro.2023.02.012_bib0004","unstructured":"Balk, E.M., Earley, A., Patel, K., Trikalinos, T.A., Dahabreh, I.J., 2013. Empirical assessment of within-arm correlation imputation in trials of continuous outcomes."},{"key":"10.1016\/j.euroneuro.2023.02.012_bib0005","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0140-6736(86)90837-8","article-title":"Statistical methods for assessing agreement between two methods of clinical measurement","volume":"327","author":"Bland","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.euroneuro.2023.02.012_bib0006","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1177\/096228029900800204","article-title":"Measuring agreement in method comparison studies","volume":"8","author":"Bland","year":"1999","journal-title":"Stat. Methods Med. Res."},{"issue":"45\u201353","key":"10.1016\/j.euroneuro.2023.02.012_bib0007","first-page":".e41","article-title":"Efficacy of low-dose buspirone for restricted and repetitive behavior in young children with autism spectrum disorder: a randomized trial","volume":"170","author":"Chugani","year":"2016","journal-title":"J. Pediatr."},{"key":"10.1016\/j.euroneuro.2023.02.012_bib0008","series-title":"Social Responsiveness Scale: SRS-2","author":"Constantino","year":"2012"},{"key":"10.1016\/j.euroneuro.2023.02.012_bib0009","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.cpr.2010.06.001","article-title":"Self-reported versus clinician-rated symptoms of depression as outcome measures in psychotherapy research on depression: a meta-analysis","volume":"30","author":"Cuijpers","year":"2010","journal-title":"Clin. Psychol. Rev."},{"key":"10.1016\/j.euroneuro.2023.02.012_bib0010","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/j.scib.2021.01.008","article-title":"Improved symptoms following bumetanide treatment in children aged 3\u22126 years with autism spectrum disorder: a randomized, double-blind, placebo-controlled trial","volume":"66","author":"Dai","year":"2021","journal-title":"Sci. Bull."},{"key":"10.1016\/j.euroneuro.2023.02.012_bib0011","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.euroneuro.2023.02.012_bib0012","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jclinepi.2005.06.006","article-title":"Imputing missing standard deviations in meta-analyses can provide accurate results","volume":"59","author":"Furukawa","year":"2006","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.euroneuro.2023.02.012_bib0013","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-010919","article-title":"Comparative efficacy and acceptability of first-generation and second-generation antidepressants in the acute treatment of major depression: protocol for a network meta-analysis","volume":"6","author":"Furukawa","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.euroneuro.2023.02.012_bib0014","unstructured":"Gamer, M., Lemon, J., Gamer, M.M., Robinson, A., Kendall's, W., 2012. Package \u2018irr\u2019. Various coefficients of interrater reliability and agreement 22, 1\u201332."},{"key":"10.1016\/j.euroneuro.2023.02.012_bib0015","unstructured":"Gilliam, J.E., 1995. GARS: Gilliam autism rating scale. Pro-ed."},{"key":"10.1016\/j.euroneuro.2023.02.012_bib0016","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1080\/1750984X.2021.1946835","article-title":"Handling effect size dependency in meta-analysis","volume":"15","author":"Gucciardi","year":"2022","journal-title":"Int. Rev. Sport Exerc. Psychol."},{"key":"10.1016\/j.euroneuro.2023.02.012_bib0017","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.euroneuro.2023.02.012_bib0018","series-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Higgins","year":"2019"},{"key":"10.1016\/j.euroneuro.2023.02.012_bib0019","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/0269881117741766","article-title":"Autism spectrum disorder: consensus guidelines on assessment, treatment and research from the British Association for Psychopharmacology","volume":"32","author":"Howes","year":"2018","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2023.02.012_bib0020","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1007\/s10578-016-0704-x","article-title":"Aripiprazole in the treatment of irritability in children and adolescents with autism spectrum disorder in Japan: a randomized, double-blind, placebo-controlled study","volume":"48","author":"Ichikawa","year":"2017","journal-title":"Child Psychiatry Hum. Dev."},{"key":"10.1016\/j.euroneuro.2023.02.012_bib0021","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13229-022-00505-6","article-title":"Large multicenter randomized trials in autism: key insights gained from the balovaptan clinical development program","volume":"13","author":"Jacob","year":"2022","journal-title":"Mol. Autism"},{"key":"10.1016\/j.euroneuro.2023.02.012_bib0022","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1001\/archgenpsychiatry.2009.30","article-title":"Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autism","volume":"66","author":"King","year":"2009","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2023.02.012_bib0023","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jcm.2016.02.012","article-title":"A guideline of selecting and reporting intraclass correlation coefficients for reliability research","volume":"15","author":"Koo","year":"2016","journal-title":"J. Chiropr. Med."},{"key":"10.1016\/j.euroneuro.2023.02.012_bib0024","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s10803-006-0213-z","article-title":"The Repetitive Behavior Scale-Revised: independent validation in individuals with autism spectrum disorders","volume":"37","author":"Lam","year":"2007","journal-title":"J. Autism Dev. Disord."},{"key":"10.1016\/j.euroneuro.2023.02.012_bib0025","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s10803-015-2628-x","article-title":"Lurasidone for the treatment of irritability associated with autistic disorder","volume":"46","author":"Loebel","year":"2016","journal-title":"J. Autism Dev. Disord."},{"key":"10.1016\/j.euroneuro.2023.02.012_bib0026","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1023\/A:1005592401947","article-title":"The Autism Diagnostic Observation Schedule\u2014Generic: a standard measure of social and communication deficits associated with the spectrum of autism","volume":"30","author":"Lord","year":"2000","journal-title":"J. Autism Dev. Disord."},{"key":"10.1016\/j.euroneuro.2023.02.012_bib0027","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1097\/CHI.0b013e3181b76658","article-title":"A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder","volume":"48","author":"Marcus","year":"2009","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.euroneuro.2023.02.012_bib0028","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.euroneuro.2021.05.010","article-title":"Drug development for Autism Spectrum Disorder (ASD): progress, challenges, and future directions","volume":"48","author":"McCracken","year":"2021","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2023.02.012_bib50","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1111\/jeb.12950","article-title":"Meta\u2010analysis of magnitudes, differences and variation in evolutionary parameters","volume":"29","author":"Morrissey","year":"2016","journal-title":"Journal of Evolutionary Biology"},{"key":"10.1016\/j.euroneuro.2023.02.012_bib0029","series-title":"Evaluating the Effectiveness of Aripiprazole and d-Cycloserine to Treat Symptoms Associated With Autism","year":"2019"},{"key":"10.1016\/j.euroneuro.2023.02.012_bib0030","series-title":"Intranasal Oxytocin for the Treatment of Children and Adolescents With Autism Spectrum Disorders (ASD) (OXY-R)","year":"2020"},{"key":"10.1016\/j.euroneuro.2023.02.012_bib0031","series-title":"The Handbook of Research Synthesis and Meta-Analysis","first-page":"357","article-title":"Stochastically dependent effect sizes","author":"Olkin","year":"2009"},{"key":"10.1016\/j.euroneuro.2023.02.012_bib0032","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1542\/peds.2008-3782","article-title":"Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder","volume":"124","author":"Owen","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.euroneuro.2023.02.012_bib0033","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.euroneuro.2023.02.012_bib0034","unstructured":"R Core Team, 2013. R: a language and environment for statistical computing."},{"key":"10.1016\/j.euroneuro.2023.02.012_bib0035","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1001\/jama.2019.14685","article-title":"Effect of fluoxetine on obsessive-compulsive behaviors in children and adolescents with autism spectrum disorders: a randomized clinical trial","volume":"322","author":"Reddihough","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.euroneuro.2023.02.012_bib0036","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1056\/NEJMoa013171","article-title":"Risperidone in children with autism and serious behavioral problems","volume":"347","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.euroneuro.2023.02.012_bib0037","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2020.550593","article-title":"Effects of probiotic supplementation on gastrointestinal, sensory and core symptoms in autism spectrum disorders: a randomized controlled trial","volume":"11","author":"Santocchi","year":"2020","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.euroneuro.2023.02.012_bib0038","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1177\/1362361313510069","article-title":"Measuring repetitive behaviors as a treatment endpoint in youth with autism spectrum disorder","volume":"19","author":"Scahill","year":"2015","journal-title":"Autism"},{"issue":"97\u2013107","key":"10.1016\/j.euroneuro.2023.02.012_bib0039","first-page":"e101","article-title":"Children's Yale-Brown obsessive compulsive scale in autism spectrum disorder: component structure and correlates of symptom checklist","volume":"53","author":"Scahill","year":"2014","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.euroneuro.2023.02.012_bib0040","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1176\/appi.ajp.2015.15010055","article-title":"Extended-release guanfacine for hyperactivity in children with autism spectrum disorder","volume":"172","author":"Scahill","year":"2015","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2023.02.012_bib0041","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1097\/01.chi.0000220854.79144.e7","article-title":"Children's Yale-Brown Obsessive Compulsive Scale modified for pervasive developmental disorders","volume":"45","author":"Scahill","year":"2006","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.euroneuro.2023.02.012_bib0042","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.zefq.2009.05.023","article-title":"GRADE: from grading the evidence to developing recommendations. A description of the system and a proposal regarding the transferability of the results of clinical research to clinical practice","volume":"103","author":"Sch\u00fcnemann","year":"2009","journal-title":"Z. Evid. Fortbild Qual. Gesundhwes"},{"key":"10.1016\/j.euroneuro.2023.02.012_bib0043","series-title":"meta: An R Package for Meta-Analysis","first-page":"40","author":"Schwarzer","year":"2007"},{"key":"10.1016\/j.euroneuro.2023.02.012_bib0044","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1037\/0033-2909.86.2.420","article-title":"Intraclass correlations: uses in assessing rater reliability","volume":"86","author":"Shrout","year":"1979","journal-title":"Psychol. Bull."},{"key":"10.1016\/j.euroneuro.2023.02.012_bib0045","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13229-020-00372-z","article-title":"Placebo response in pharmacological and dietary supplement trials of autism spectrum disorder (ASD): systematic review and meta-regression analysis","volume":"11","author":"Siafis","year":"2020","journal-title":"Mol. Autism"},{"key":"10.1016\/j.euroneuro.2023.02.012_bib0046","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13229-022-00488-4","article-title":"Pharmacological and dietary-supplement treatments for autism spectrum disorder: a systematic review and network meta-analysis","volume":"13","author":"Siafis","year":"2022","journal-title":"Mol. Autism"},{"key":"10.1016\/j.euroneuro.2023.02.012_bib0047","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v036.i03","article-title":"Conducting meta-analyses in R with the metafor package","volume":"36","author":"Viechtbauer","year":"2010","journal-title":"J. Stat. Softw."},{"key":"10.1016\/j.euroneuro.2023.02.012_bib0048","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.1093\/brain\/awv249","article-title":"Clinical and neural effects of six-week administration of oxytocin on core symptoms of autism","volume":"138","author":"Watanabe","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.euroneuro.2023.02.012_bib0049","series-title":"Vector Generalized Linear and Additive Models: With an Implementation in R","author":"Yee","year":"2015"}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X23000391?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X23000391?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T18:05:39Z","timestamp":1760378739000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X23000391"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":50,"alternative-id":["S0924977X23000391"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2023.02.012","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinician- versus caregiver-rated scales as outcome measures of repetitive-restricted behaviors in clinical trials of autism: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2023.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. and ECNP. All rights reserved.","name":"copyright","label":"Copyright"}]}}